跳至主要内容
临床试验/NCT06570096
NCT06570096已完成不适用

Premixed Versus Sequential Injections of Lidocaine and Bupivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Arteriovenous Fistula Creation: A Randomized Clinical Trial

Tanta University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年8月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Percentage of participants with a complete four-nerve sensory block

研究概览

简要总结

This study aims to compare premixed and sequential injections of lidocaine and bupivacaine for supraclavicular brachial plexus block in patients undergoing arteriovenous fistula creation.

详细描述

Hemodialysis is the common treatment for end-stage renal disease (ESRD) condition which improves quality of life and survival rate for this group of patients. Arteriovenous fistula (AVF) creation is the vascular access technique that provides long-term vascular access for hemodialysis patients.

Ultrasound-guided supraclavicular brachial plexus block (SCBPB) is a widely accepted and effective technique for AVF creation procedures. It provides analgesia, sympathetic blockade, optimal surgical conditions, and adequate duration of postoperative block that prevents arterial spasm and graft thrombosis. It offers higher blood flow in the radial artery and arteriovenous fistula than is achieved with infiltration anesthesia.

Lipid-soluble local anesthetics (LA) such as ropivacaine and bupivacaine are generally more potent and have a significantly longer duration of action as well as a more prolonged onset of action compared to intermediate-potency drugs such as lignocaine, mepivacaine, and prilocaine. A combination of two LAs is often used in regional blocks to utilize the different clinical properties of the drugs to achieve a faster onset and longer block duration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age from 18 to 65 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) physical status III.
  • Undergoing arteriovenous Fistula creation.

排除标准

  • Allergy to local anesthetics.
  • Body mass index (BMI) ≥ 35 kg/m
  • Preoperative neurological deficit.
  • Neuromuscular disorder.
  • Psychiatric disorder.
  • Coagulation disorder.
  • Congestive heart failure.
  • Pregnancy.
  • Infection at the site of block.

研究组 & 干预措施

Sequential Injections group

Experimental

Patients will receive 10 ml of lidocaine 2% then 10 ml of bupivacaine 0.5% with a delay of 120s between injections.

干预措施: Lidocaine 2% then bupivacaine 0.5% (Drug)

Premixed Injections group

Active Comparator

Patients will receive 20 ml of freshly prepared mixtures of 10 ml of lidocaine 2% and 10 ml of bupivacaine 0.5%

干预措施: Lidocaine 2% and bupivacaine 0.5% (Drug)

结局指标

主要结局

Percentage of participants with a complete four-nerve sensory block

时间窗: With in 10 minutes intraoperatively

Percentage of participants with a complete four-nerve sensory block at 10 minutes will be recorded.

次要结局

  • Time of onset of sensory block(Intraoperatively)
  • Degree of pain(24 hours postoperatively)
  • Time of onset of motor block(Intraoperatively)
  • Time to the 1st rescue analgesia(24 hours postoperatively)
  • Incidence of adverse events(24 hours postoperatively)
  • Degree of patient satisfaction(24 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohammed Said ElSharkawy

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tanta University

研究点 (1)

Loading locations...

相似试验

Premixed vs Sequential Injections of Lidocaine and... | 临床试验